Back to Browse Journals » Vascular Health and Risk Management » Volume 5

Validation of reported physical activity for cholesterol control using two different physical activity instruments

Authors Amy Z Fan, Sandra A Ham, Shravani Reddy Muppidi, et al

Published 6 August 2009 Volume 2009:5 Pages 649—661

DOI https://dx.doi.org/10.2147/VHRM.S6164

Review by Single-blind

Peer reviewer comments 2

Amy Z Fan1, Sandra A Ham2, Shravani Reddy Muppidi3, Ali H Mokdad4

1Behavioral Surveillance Branch, Division of Adult and Community Health, National Center for Chronic Disease Prevention and Health Promotion; 2Physical Activity and Health Branch, Division of Nutrition, Physical Activity, and Obesity, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA; 3College of Public Health, University of Georgia, Athens, GA, USA; 4Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA

Abstract: The National Cholesterol Education Program recommends increasing physical activity to improve cholesterol levels and overall cardiovascular health. We examined whether US adults who reported increasing their physical activity to control or lower blood cholesterol following physician’s advice or on their own efforts had higher levels of physical activity than those who reported that they did not. We used data from the National Health and Nutrition Examination Survey 2003–2004, which implemented two physical activity assessment instruments. The physical activity questionnaire (PAQ) assessed self-reported frequency, intensity, and duration of leisure-time, household, and transportation-related physical activity in the past month. Physical movement was objectively monitored using a waist accelerometer that assessed minute-by-minute intensity (counts of movement/minute) during waking time over a 7-day period. We adjusted our analysis for age, gender, race/ethnicity, educational attainment, and body mass index. Participants who reported increasing physical activity to control blood cholesterol had more PAQ-assessed physical activity and more accelerometer-assessed active days per week compared to those who did not. However, there were no significant differences in cholesterol levels between comparison groups. These findings suggest that self-report of exercising more to control or lower cholesterol levels among US adults might be valid.

Keywords: accelerometer, cardiovascular diseases, hypercholesterolemia, physical activity, risk reduction behavior

General overview

Physical activity is beneficial to control healthy blood cholesterol levels and maintain heart health. Doctor's advice may help individuals to increase physical activity level. In this study we investigated whether participants who reported increasing their physical activity to control blood cholesterol following physician's advice or on their own efforts indeed are more active than their counterparts. We verified participants' report by a survey questionnaire and an actual instrument carried by the participants. We found that participants who reported increasing physical activity to control blood cholesterol are indeed more active. However, there were no significant differences in cholesterol levels between respective comparison groups. These findings suggest that self-report of exercising more to control or lower cholesterol levels among US adults might be valid but insufficient. More intensive interventions are needed to encourage exercise and increase physical activity in the general population and in individuals who had high cholesterol conditions.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Other article by this author:

Readers of this article also read:

P-wave and QT dispersion in patients with conversion disorder

Izci F, Hocagil H, Izci S, Izci V, Koc MI, Acar RD

Therapeutics and Clinical Risk Management 2015, 11:475-480

Published Date: 26 March 2015

Perindopril for improving cardiovascular events

DiNicolantonio JJ, O’Keefe JH

Vascular Health and Risk Management 2014, 10:539-548

Published Date: 30 August 2014

Factors influencing dyslipidemia in statin-treated patients in Lebanon and Jordan: results of the Dyslipidemia International Study

Azar ST, Hantash HA, Jambart S, El-Zaheri MM, Rachoin R, Chalfoun A, Lahoud L, Okkeh O, Bramlage P, Brudi P, Ambegaonkar BM

Vascular Health and Risk Management 2014, 10:225-235

Published Date: 7 May 2014

Postmarketing safety experience with edoxaban in Japan for thromboprophylaxis following major orthopedic surgery

Kuroda Y, Hirayama C, Hotoda H, Nishikawa Y, Nishiwaki A

Vascular Health and Risk Management 2013, 9:593-598

Published Date: 7 October 2013

Persistent middle cerebral artery occlusion associated with lower body temperature on admission

Kvistad CE, Øygarden H, Thomassen L, Waje-Andreassen U, Naess H

Vascular Health and Risk Management 2013, 9:297-302

Published Date: 17 June 2013

Percutaneous mechanical thrombectomy for treatment of acute femoropopliteal bypass occlusion

Lichtenberg M, Käunicke M, Hailer B

Vascular Health and Risk Management 2012, 8:283-289

Published Date: 4 May 2012

Comparison of outcome in 1809 patients treated with drug-eluting stents or bare-metal stents in a real-world setting

Vogt A, Schoelmerich A, Pollner F, Schlitt M, Raaz U, Maegdefessel L, Reindl I, Buerke M, Werdan K, Schlitt A

Vascular Health and Risk Management 2011, 7:693-699

Published Date: 22 November 2011

Update on the everolimus-eluting coronary stent system: results and implications from the SPIRIT clinical trial program

R Michael Kirchner, J Dawn Abbott

Vascular Health and Risk Management 2009, 5:1089-1097

Published Date: 16 December 2009

Pattern of heart failure in a Nigerian teaching hospital

Arthur C Onwuchekwa, Godspower E Asekomeh

Vascular Health and Risk Management 2009, 5:745-750

Published Date: 7 September 2009

Prognostic stratification of acute pulmonary embolism: Focus on clinical aspects, imaging, and biomarkers

Luca Masotti, Marc Righini, Nicolas Vuilleumier, Fabio Antonelli, et al.

Vascular Health and Risk Management 2009, 5:567-575

Published Date: 2 July 2009